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The mammary gland is a unique organ that continually undergoes postnatal developmental changes. In mice, the mammary gland
is formed via signals from terminal end buds, which direct ductal growth and elongation. Intriguingly, it is likely that the entire
cellular repertoire of the mammary gland is formed from a single antecedent cell. Furthermore, in order to produce progeny
of varied lineages (e.g., luminal and myoepithelial cells), signals from the local tissue microenvironment inﬂuence mammary
stem/progenitor cell fate. Data have shown that cells from the mammary gland microenvironment reprogram adult somatic cells
from other organs (testes, nerve) into cells that produce milk and express mammary epithelial cell proteins. Similar results were
found for human tumorigenic epithelial carcinoma cells. Presently, it is unclear how the deterministic power of the mammary
gland microenvironment controls epithelial cell fate. Regardless, signals generated by the microenvironment have a profound
inﬂuence on progenitor cell diﬀerentiation in vivo.
1.Introduction
The ﬁrst documented description of cells with stem-like pro-
perties that were found in a deﬁned environment occurred
over one century ago when Alexander Maximov suggested
that certain cells located in the hematopoietic system had
regenerative properties [1]. Many years later, McCulloch
and Till identiﬁed self-renewing cells in the mouse bone
marrow [2]. More recently, Evans, Kaufman, and Martin
demonstrated that embryonic stem cells were present in the
innercellmassofamouseembryo[3,4].Foundwithinevery
tissue of the body, stem/progenitor cells reside and perform
distinct cellular functions that maintain tissue homeostasis.
Directing those functions is the surrounding environment,
which consists of stroma, epithelium, and other cell types
native to the area.
2. The Concept of the Niche
Identiﬁed over 30 years ago while studying the hematopoetic
system, R. Schoﬁeld ﬁrst coined the term “niche” (also
known as a local tissue microenvironment) when deﬁning
the microanatomical space that includes all cellular, molec-
ular, and physical factors that interact with and regulate
as t e mc e l l[ 5]. Tissue-speciﬁc niches (microenvironments)
constitute a basic unit of physiology, which integrate signals
relayed to cells of the niche for interpretation [6]. It has
been found that, when explanted into 2D culture conditions,
cells of the niche often lose their normal tissue-speciﬁc func-
tions, suggesting that the tissue microenvironment regulates
progenitor cell fate [7]. When placed back into conditions
that more closely resemble the tissue microenvironment, the
cell regains speciﬁc traits and functions and appears more
normal [8].
The concept of the niche has been well-deﬁned utilizing
Caenorhabditis elegans and Drosophila melanogaster [9].
Studies using these two models emphasize the importance
of both cell-cell contact as well as diﬀusible factors in the
management of cellular fate. For example, asymmetric cell
division of the germline stem cell of C. elegans is regulated
by a niche cell called the distal tip cell. The distal tip
cell expresses the ligand delta homologue Lag-2, where the2 International Journal of Cell Biology
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Figure 1: Asymmetric cellular division and signaling in the C. elegans germinal stem cell niche. (a) C. elegans is composed of a distal tip cell
(blue), which maintains a niche for the germline stem cells (dark purple) and diﬀerentiated germ cells (pink). (b) Binding of Lag-2, which is
expressed on the distal tip cell, to the Glp-1 receptor (expressed on the germline stem cell) leads to mitosis. If Lag-2 does not bind to Glp-1,
Gld-1 accumulates in the cell, favoring meiosis.
germline stem cells express the receptor Glp-1 [10]. Binding
of Lag-2 with Glp-1 leads to mitotic division of the germline
stem cells in C. elegans (Figure 1). Alternatively, a reduction
in binding (and the subsequent accumulation of the RNA-
binding protein Gld-1) results in the germline stem cells
undergoing meiosis [11]( Figure 1). Furthermore, diﬀusible
factors such as those found in the Wnt signaling pathway
aﬀect the development of distal tip cells. Loss of function
of pop-1 and sys-1 (C. elegans homologues to mammalian
Tcf and β-catenin, resp.) leads to decreased production of
distaltipcells,whichfavorsmeioticdivisionbydiﬀerentiated
germ cells in C. elegans [12]. Similar events, highlighting the
importance of physical contact and diﬀusible factors of the
tissue microenvironment in the maintenance and regulation
of germline stem cells, have also been well documented in D.
melanogaster [9, 13, 14].
3.Mammary GlandStructure
The mouse mammary gland is a robust model for exam-
ining the inﬂuence of the tissue microenvironment on
stem/progenitor cells. It has been found that a functional
mouse mammary gland can be regenerated from as little as
one mammary progenitor cell [15, 16], in addition to being
regenerated by any portion of the gland itself [17, 18]. This
characteristic of the niche does not change over time or vary
based on reproductive history [19]. Therefore, it is likely
that mammary stem/progenitor cells are maintained within
microenvironments of the mammary gland throughout life.
Th em a m m a rygl a n di sc o m po s edo ft w oti s s u ec o m p a rt -
ments separated by a basement membrane: the epithelium,
which includes the ducts and lobules, and the stroma,
which consists of the connective tissue that constitutes the
mammary fat pad [20]. In the nonlactating adult breast,
the stroma occupies that majority of the tissue, where
the proportions of ﬁbrous and adipose tissue vary with
age [21]. Within the stroma, breast tissue consists of a
complex network of lobules and mammary ducts, and fat.
Breast lobules, comprised of groups of alveoli (also called
acini or terminal ductules), are spherical-shaped, glandular
structures that produce milk [21]. Within the alveoli, a single
layerofluminalepithelialcellsthatsurroundtheinnerlumenInternational Journal of Cell Biology 3
can be found [22]. Adjacent to the luminal cells exists a layer
of myoepithelial cells responsible for basement membrane
protein deposition as well as providing contractile motion
during milk secretion [23, 24]. During pregnancy, epithelial
cells of the alveoli undergo extensive proliferation, leading
to an increase in the number of alveolar units, and therefore
increaseinthesizeandnumberoflobules[21].Themilkthat
is produced by breast lobules is then drained by a branching
network of ducts that carry milk from the lobules to the nip-
ples during lactation [25]. Ducts that drain individual alveoli
lead to progressively larger ducts, which connect with the
nipple [21, 22]. At the nipple, the ducts expand to form lact-
iferous sinuses. The sinuses then terminate into cone-shaped
ampullae immediately below the surface of the nipple [21].
4.Factorsthat Regulateand Maintainthe
Mammary Niche
It has been shown that the entire functional mammary
gland epithelial outgrowth may be comprised of the progeny
from a single cell [16]. These components, progenitor
cells, basement membrane, and extracellular matrix, are
the basic functional units of a tissue microenvironment.
These structures, along with cell-cell communication and
solublefactors,createafunctionalsignalingnichethatdirects
cellular activity via direct contact or via paracrine signaling
(Figure 2). The mammary gland microenvironment is a
complex network of intracellular communication between
luminal cells, basal cells, and the stroma [26]. In addition
to the hormones necessary for mammary ductal and lobule
development (estrogen and progesterone), a variety of other
factors compose the mammary niche including physical
factors such as cell-cell contact and diﬀusible factors such as
hormones and cytokines.
5. Cellular Components
The mammary gland and surrounding stroma are made
up of a variety of cell types that constitute the mammary
gland microenvironment. Cells comprising the mammary
gland niche include epithelial cells, adipocytes, ﬁbroblasts,
endothelial cells, neural cells, and lymphoid cells. It is
estimated that these cells are either supporting cells for, play
a role in, secrete soluble factors towards, or are regulated by
mammary gland development [27–29]. It has been shown
that macrophages and perhaps their signals are essential for
ductal development as well as support mammary stem cell
function (Figure 2)[ 30, 31]. In the absence of macrophages
or colony stimulating factor-1 (CSF-1), mammary stem cell
function, including outgrowth potential and regenerative
capability, is severely compromised [30]. Macrophages,
eosinophils, and their respective cytokines, including CSF-
1 and eotaxin are required for terminal end bud formation.
These cells are also found near the mammary gland acini
during pregnancy and lactation [32]. Landskroner-Eiger et
al. and Couldrey et al. found that adipocytes are essential for
the formation of the mammary gland ducts during puberty
(Figure 2)[ 33, 34]. In addition, adipocytes were also found
to maintain alveolar buds that are formed during pregnancy
[33]. In the absence of adipocytes, rudimentary structures in
the mammary gland are formed, but ductal branching does
not occur [34]. Finally, stromal ﬁbroblasts have been found
to inﬂuence human mammary epithelial cell morphogenesis
(Figure 2)[ 35].
6.Diffusible Factors
6.1. Hormones and Their Receptors. Two major hormones
are typically found in the mammary gland and are essential
for normal mammary gland development: estrogen and pro-
gesterone (Figure 2). During puberty, ductal development
is driven predominantly by estrogen [20]. As a mature
virgin, progesterone regulates side branching of the ducts,
whileprolactin,progesterone,placentallactogens,andErbB4
initiate alveolar bud formation during pregnancy [20].
During lactation, prolactin and ErbB4 typically drive milk
production [20].
In addition, the hormone receptors, estrogen receptor
(ER) and progesterone receptor (PR), are needed for mam-
mary gland development. In particular, ER-α is predomi-
nantly expressed in luminal cells but can also be found in
the nuclei of ductal epithelial cells (Figure 2)[ 21]. ER-α is
typically not expressed in myoepithelial cells [21]. Most ER-
α-positive cells are negative for Ki-67 during premenopause,
suggesting that the majority of ER-α-positive cells do not
undergo proliferation during that time. However, as a
woman increases in age, the number of ER-α-positive cells
that undergo proliferation increase, eventually reaching a
plateau after menopause [21]. Loss of ER-α is associated with
impairedbranchingandelongationofmammaryglandducts
[36, 37]. A second estrogen receptor, ER-β, is also known to
be expressed in the mammary gland. ER-β is expressed in the
epithelial cells of ducts and lobules, as well as myoepithelial
cells and cells of the stroma.
PR is expressed in the luminal epithelial cells of the ducts
and lobules (Figure 2). Data have shown that the formation
of both PR-positive and PR-negative cells is mediated by
progesterone [36]. In contrast to ER-α,h o w e v e r ,P Rh a sn o t
been found to vary with stage of menstruation [21]. In a PR
−/− mutant mouse model (where the transcription of both
the A and B forms of PR is disrupted), the development of
secretory alveoli is impaired [36, 37].
Estrogen receptors, in particular, are mediated by the
epidermal growth factor family member amphiregulin
(Figure 2)[ 37, 38]. Amphiregulin, a heparin-binding, gly-
cosylated protein, is required for ductal and terminal end
buddevelopment[39].Inthemammaryglandsofmammals,
during puberty amphiregulin is expressed in myoepithelial
cells, luminal cells, and cap cells located in the terminal end
bud [39].
6.2. Cytokines. Two main cytokine signaling pathways have
been implicated in mammary progenitor cell maintenance:
RANKL and Wnt/β-catenin. Wnt4, in particular, is a key
factorthatmediatesprogesteroneand,thus,mammarygland
side branching (Figure 2)[ 40]. Furthermore, addition of
Wnt3A protein to mammary stem cells in culture leads to
stem cell expansion for consecutive generations (Figure 2)4 International Journal of Cell Biology
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Figure 2: The mammary gland microenvironment. The major cell types of the mammary gland, luminal epithelial (luminal compartment)
and myoepithelial cells (basal compartment), are separated from the stromal compartment by a basement membrane. Both the luminal
epithelial and myoepithelial cell growths are mediated by adipocytes and ﬁbroblasts located within the stroma, as well as by estrogen,
progesterone, prolactin, TGF-α,T G F - β, STAT5a, STAT5b, EGF, IGF, and RANKL signaling. Wnt3A signaling regulates mammary stem cells
present in the luminal compartment. IGF mediates the mammary gland’s response to estrogen, while RANKL, IGF, and Wnt4 mediate the
response to progesterone. IGF additionally regulates prolactin signaling. Estrogen receptor expression is mediated by amphiregulin.
[41]. When transplanted, stem cells treated with Wnt3A pro-
tein exhibited robust growth when compared to implanted
mammary stem cells that were not treated [41]. Receptor
activator of nuclear factor-κβ ligand (RANKL), on the other
hand, has been shown to mediate the mouse mammary
epithelium’s proliferative response to progesterone during
mammary lactational morphogenesis (Figure 2)[ 42]. Fur-
thermore, Fata et al. showed that the mammary glands of
RANK-andRANKL-deﬁcientmiceexhibitnormalglandular
development during sexual maturation, yet do not form
lobuloalveolarstructuresduringpregnancy[43].Inaddition,
RANKL has been found to increase the proliferation of
daughter cells that are formed following stem cell asymmet-
ric division [44, 45].
6.3. Growth Factors. In the mammary gland, the transform-
ing growth factor-β (TGF-β) superfamily plays a critical
role in gland development. Three TGF-β ligands, TGF-β1,
TGF-β2, and TGF-β3, signal through type I and type II
TGF-β receptors. Phosphorylation of the receptors leads to
signaling through one of four main pathways: the Smad
signaling pathway and the PI3-kinase, and the TAK1 and
RhoApathways[46].TheTGF-β isoforms,inparticular,help
maintain tissue homeostasis in terminal end buds and mam-
mary ducts by limiting cellular proliferation (Figure 2)[ 47].
Delayed ductal formation has been found to be associated
with an overexpression of TGF-β1[ 47]. Furthermore, TGF-
β was seen to increase in expression during pregnancy [48].
Finally, TGF-β1, TGF-β2, and especially TGF-β3w e r ef o u n d
to increase in expression during involution suggesting a role
in glandular apoptosis [49].
TGF-β is also a major inducer of the epithelial-
mesenchymal transition (EMT). During EMT, the cellular
expression of proteins involved in adhesion are lost [50].
Simultaneously, these cells lose all characteristics pertaining
to an epithelial phenotype [50]. On the other hand, cellsInternational Journal of Cell Biology 5
undergoingEMTshowincreasedexpressionofmesenchymal
proteins such as α-smooth muscle actin and vimentin [50].
As a result, these cells show an increased ability to migrate.
Cells that typically undergo EMT include progenitor cells
and tumor cells [51, 52]. TGF-β,i np a r t i c u l a r ,i sap o t e n t
inducer of Snail1, which in turn increases the expression of
proinﬂammatory interleukins such as interleukin 6 (IL-6)
[53]. Elevated serum levels of IL-6, a pleiotropic cytokine,
have been correlated with advanced breast tumor stage,
metastasis, and poor prognosis [54]. MCF7 metastatic breast
cancer cells have been shown to constitutively express IL-6,
which is associated with increased expression of Snail1 and
Twist1, and exhibit an EMT phenotype [55].
Other inducers of mammary development that inﬂu-
ence the mammary gland microenvironment include the
signaltransducerandactivatoroftranscription-5a(STAT5a),
STAT5b, and the epidermal growth factor (EGF) family of
growthfactorsandtheirreceptors.BothSTAT5aandSTAT5b
signal through the prolactin receptor to control mammary
gland proliferation and diﬀerentiation (Figure 2)[ 20]. It was
found that inactivation of STAT5a leads to a failure of lacta-
tiontooccur,eventhoughproliferationandexpansionofthe
alveolar compartment had occurred essentially normal [20].
In addition, the EGF family of growth factors and receptors,
amphiregulin, and transforming growth factor-α [26]a r e
expressed during postnatal mammary gland development.
Amphiregulin, as previously mentioned, is necessary for
ductal development and the formation of terminal end buds
[38]. Transforming growth factor-α expression has been
found in the proliferating cap of cells of the terminal end
buds (Figure 2)[ 56]. EGF is essential for mammary cell
proliferation and diﬀerentiation (Figure 2)[ 56]. Many of the
E G Ff a m i l yr e c e p t o r s ,E G Fr e c e p t o r ,e r b B 1 ,e r b B 2 ,e r b B 3 ,
and erbB4, are expressed either in virgin females, during
pregnancy, or during lactation [26].
Another important signal in the mammary microenvi-
ronment is the stroma-derived factor insulin-like growth
factor (IGF). IGF is an important mammary growth factor
regulating hormonal control of ductal growth (Figure 2)
[57]. It was found that IGF-1 null mice have diminished
ductal growth and terminal end bud formation, suggesting
that IGF-1 is necessary for ductal branching and the
production of terminal end buds in developing mammary
gland [58]. In addition, IGF-1 as well as IGF-2 has been
found to regulate the expression of estrogen, progesterone,
prolactin, and growth hormone in the mammary gland
(Figure 2)[ 57]. IGF-1 and estrogen act as mitogens in the
development of the normal mammary gland. Increased IGF-
1 and estrogen expression lead to an increase in mammary
epithelial cell proliferation [59]. Furthermore, it has been
found that IGF-1 executes its growth factor control as
an autocrine, paracrine, and endocrine regulatory signal
[57]. Both IGF-1 and IGF-2 are expressed in the terminal
end buds and mammary stroma. IGF-1 mediates alveolar
budding and proliferation during pregnancy [60]. Increased
circulating IGF-1 levels lead to acceleratedmammary growth
[57]. Thus, IGF-1 is a necessary factor for mammary gland
development.
7. β1IntegrinasaKeyRegulatorinMammary
Gland Regeneration and Development
The mammary microenvironment can also inﬂuence the
behavior of epithelial cells by altering the composition of the
extracellular matrix. In particular, the extracellular matrix
aﬀects signaling pathways of integrins, which have been
shown to play a major role during cellular growth and
diﬀerentiation.
Integrins are a type of receptor that mediate interaction
with the extracellular matrix [61]. In addition, integrins
are involved in cell motility and in deﬁning cell shape.
Integrins are transmembrane heterodimers, composed of
two noncovalently associated glycoprotein α and β subunits.
Once bound with their ligand, integrins activate intracellular
signaling pathways such as the MAP kinase pathway [61].
β1 integrin heterodimers, in particular, are important for
a variety of cellular functions including skin, hair, nerve,
and chondrocyte development [62–64]. In addition, β1
integrin has been implicated in mammary epithelial cell
proliferation, survival, and diﬀerentiation [65, 66]. Recent
reports have shown that the ablation of the β1 integrin
gene leads to retarded mammary gland growth, and altered
lobuloalveolar development and ductal branching pattern
[67]. Furthermore, β1 integrin was found to play a critical
role in the alveolar development of glandular epithelium
and was required for mammary epithelial cell diﬀerentiation
[68]. Thus, these data suggest that β1 integrin is a key
regulator of the activity of mammary stem/progenitor cells.
In order to further investigate whether β1 integrin is
required for mammary stem cell maintenance as well as
alveolar development, mammary epithelial/progenitor cells
were isolated from Itgβ1fx/fx,C r e E R δ mice and treated with
4-OH-Tamoxifen (Bussard, unpublished data). Addition of
Tamoxifen will cause CreERδ to dissociate from Hsp90,
allowing the CreERδ to translocate to the nucleus, and cut
and remove the ﬂoxed β1 integrin gene (Figure 3). This
event occurs in mammary epithelial/progenitor cells, as well
as any cell containing a CreERδ/Hsp90 complex in the
mammary epithelium, and allows for the determination of
the gene’s importance in mammary gland development. In
ﬁrst-generation implants, glandular growth was absent in
89% of mammary glands divested of mammary epithelium
that were implanted with Itgβ1fx/fx, CreER mammary epithe-
lial cells treated with 4-OH-Tamoxifen (Table 1) (Bussard,
unpublished data). These results suggest that β1 integrin is
necessary for mammary stem cell maintenance and mam-
mary gland development. In second-generation implants,
glandular growth was present in ∼60% of outgrowths
(Table 2) (Bussard, unpublished data). Mice implanted with
Itgβ1fx/fx, CreER mammary epithelial cells treated with 4-
OH-Tamoxifen were additionally mated to examine the
role of β1 integrin in mammary gland development during
pregnancy. Similar to second-generation implants, glandular
growth was present in ∼60% of outgrowths (Table 2)( B u s -
sard, unpublished data). These data, coupled with similar
results obtained for the second-generation nonpregnant
implants previously described, suggest that removal of β1
integrin in the epithelium leads to a reduction in outgrowth6 International Journal of Cell Biology
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Figure 3: Deletion of β1 integrin using Tamoxifen. (a) No
Tamoxifen, gene active. The active gene, β1 integrin, resides ﬂoxed
in the nucleus. Complexes of Hsp90 (red) and CreERδ (green)
reside in the cytoplasm. (b) Tamoxifen added, gene inactive. When
Tamoxifen is added, CreERδ (green) is dissociated from Hsp90
(red),allowingittotranslocatetothenucleusandremovetheﬂoxed
β1 integrin.
eﬃciency. Additional work is needed to fully elucidate the
role of β1 integrin in mammary gland development.
8. Mammary GlandMicroenvironmental
Control of Progenitor Cells
What factors in the mammary gland microenvironment,
in particular, inﬂuence progenitor/epithelial cell fate? Most
likely,thereareacombinationofcell-cell,cell-solublefactors,
and cell-extracellular matrix interactions that take place
t ob o t hm a i n t a i na sw e l la sd i ﬀerentiate progenitor cells
[69, 70]. To tackle this technically challenging question,
Labarge et al. recently developed an interesting technology
utilizing microenvironment protein microarrays to identify
combinations of mammary gland proteins and molecules
from the extracellular matrix that inﬂuenced mammary
gland progenitor cell fates [71]. It was reported that jagged1
maintains the pool of progenitor cells [71]. Furthermore,
laminin1 was found to maintain mammary gland progenitor
cells in a quiescent state [71]. For diﬀerentiation into myoep-
Table 1: Number of positive outgrowths from mammary glands
divested of epithelium and inoculated with various amounts of
untreated or Tamoxifen-treated Itgβ1fx/fx,C r e E RC e l l s .
No. of inoculated cells Untreated (control) Treated with
Tamoxifen
50,000 2/4 1/4
100,000 1/2 0/4
500,000 1/1 0/1
Total 4/7 1/9
Table 2: Number of positive outgrowths from mammary glands
divested of epithelium and inoculated with fragments from
untreated or Tamoxifen-treated Itgβ1fx/fx, CreER Mouse mammary
glands.
State of parity Untreated (control) Treated with Tamoxifen
Non-pregnant 9/12 7/12
Pregnant 13/16 10/18
ithelial cells, the investigators discovered that expression of
P-cadherin in the mammary gland microenvironment led to
progenitor cell diﬀerentiation into basal cells [71]. On the
other hand, it was found that cell-cell contact, or expression
of E-cadherin, facilitated progenitor cell diﬀerentiation into
luminal epithelial cells [71]. Thus, these results suggest that
expression of speciﬁc proteins within the tissue microenvi-
ronment can mediate progenitor cell fate.
9. Notch, Amphiregulin,or the Hedgehog
SignalingPathwaysMayMediatetheCell
Fate of Mammary Stem/Progenitor Cells
Recent studies have indicated that factors such as Notch,
amphiregulin, or the Hedgehog signaling pathways are
responsible for the glandular development of the branching
mammary fat pad. Amphiregulin, as previously discussed,
is a member of the epidermal growth factor family and
regulates mammary gland morphogenesis via paracrine
activation of the epidermal growth factor receptor [72].
In experiments conducted by Booth et al., amphiregulin
expression was knocked down in an immortal mammary
epithelial cell line with stem cell characteristics via siRNAs
[72]. Data showed that amphiregulin not only controlled
ductal elongation but also mediated progenitor cell self-
renewal [72]. In addition to amphiregulin, Notch has been
reported to regulate mammary stem/progenitor cell fate.
When examined in a mammosphere culture, it was found
that a synthetic peptide derived from the Delta-Serrate-
LAG 2 (DSL) domain, which is conserved in all Notch
ligands, promoted stem cell self-renewal, as well as regulated
asymmetric progenitor cell division [73]. In later stages of
mammary gland development, the same DSL peptide was
found to promote myoepithelial cell development [73]. The
DSL peptide was not found to aﬀect fully diﬀerentiatedInternational Journal of Cell Biology 7
mammary epithelial cells, suggesting that the eﬀects of
the Notch-derived peptide are limited to early mammary
progenitor cells [73].
Finally,inadditiontoamphiregulinandNotch,members
of the Hedgehog signaling pathway and Bmi-1 have been
found to regulate the self-renewal of mammary stem cells.
Hedgehog signaling, which includes the genes PTCH1, Gli1,
Gli2, and Bmi-1, was found to increase the number of
mammosphere-initiating cells as well as increase mammo-
sphere size [74]. Upon further investigation, it was found
that higher concentrations of these genes were expressed
in mammary progenitor cells, whereas their concentrations
were reduced in more diﬀerentiated cells [74]. Further-
more, the proteins Sonic Hedgehog and Indian Hedgehog
have been found to be expressed in more diﬀerentiated
mammary epithelium [75, 76], whereas Desert Hedgehog
expression is higher in terminal end buds when compared
to mammary stroma [77]. In addition, it has been found
that the protein Gli2 is expressed in the stroma surrounding
ducts of the mammary gland as well as in the terminal
end buds [78]. Gli3, on the other hand, is located in the
more diﬀerentiated mammary gland epithelium and stroma
[79]. Proteins in the Hedgehog family regulate multiple
phases of mammary gland development, including ductal
development and lactation [80]. These results suggest that,
in addition to amphiregulin and Notch, members of the
Hedgehog signaling pathway play a role in the regulation and
self-renewal of mammary progenitor cells.
As a direct example of the microenvironment controlling
progenitor cells, our laboratory recently demonstrated that
themousemammarymicroenvironmentcouldredirectadult
mouse cells of non-mammary origins to expand and dif-
ferentiate to mammary epithelial cell fates during glandular
regeneration in vivo [81, 82]. It was found that both adult
testicular cells and bona ﬁde neural stem cells could be
reprogrammed by the mouse mammary gland to behave as
mammary epithelial cells [81, 82]. For the adult testicular
cells, a mixture of 10% spermatogonia Types A and B, 28%
Sertoli cells, and 62% diﬀerentiating spermatocytes isolated
from the seminiferous cords of adult male WAP-Cre/Rosa26
R mice was implanted with female mammary epithelial cells
into the epithelium-free fat pad of three week old female
athymicnudemice.Sixtoeightweekslater,miceweremated,
allowed to come to a full term pregnancy, and subsequently
euthanized. Glands were harvested and examined for the
presence of mammary cell markers casein (milk) and keratin
5(myoepithelialcellmarker)whichweredetectedamongthe
inoculated male cell progeny [81]. In addition, ﬂuorescent in
situ hybridization revealed that both male (spermatogenic,
Y chromosome) and female (mammary, double X chromo-
some) cells were juxtaposed to one another and were present
in the same acinus [81]. These results were seen in both ﬁrst
and secondary generation transplants, and indicated that
male progenitor cells contributed toward the formation of a
functional female mammary gland. A similar approach was
carried out to examine if the mammary microenvironment
could reprogram embryonic and adult neural stem cells
isolated and propagated in selective neural stem cell medium
as bona ﬁde neural stem cells. Comparable to that found
with testicular cells, it was seen that WAP-Cre/Rosa26 R
neural stem cells could also be redirected to express the
mammary epithelial cell marker casein (milk) [82]. These
results, in addition to those discussed by Bussard, et al.
[83], demonstrate that the behavior of the stem/progenitor
cell is dependent on the microenvironment in which it is
in, suggesting a dominance of the tissue-speciﬁc niche over
progenitor cell fate.
10. The Microenvironmentand Cancer
There is increasing evidence which suggests that the tis-
sue microenvironment can also regulate the malignant
phenotype of tumors. Beginning in 1975, Mintz and Ill-
mensee injected embryonal carcinoma cells either subcuta-
neously into mice or into blastocysts that were subsequently
implanted into pseudopregnant hosts [84]. Teratocarcino-
mas formed in mice directly inoculated with embryonal
carcinoma cells. However, when embryonal carcinoma cells
wereinoculatedintoblastocystsandimplantedintopregnant
hosts, “normal” chimeric mice were produced with no
tumor development [84]. Furthermore, the oncogenic virus,
Rous sarcoma virus, causes aggressive tumors when injected
directly into the wings of chickens [85]. However, when
chicken embryos were infectedin ovo with tagged pp60src (the
nonreceptor protein tyrosine kinase that mediates the Rous
sarcoma virus’s activity), no tumors formed even though the
virus was expressed in a majority of cells in the infected
embryos [86]. When grown in culture, cells from these
embryos formed tumors [86]. These studies suggest that the
“normal” tissue microenvironment is dominant over tumor
formation. More recently, it was demonstrated by Felsher
that bona ﬁde oncogenes are tumorigenic only in certain
cell lines [87]. In order to become tumorigenic, Felsher
discovered that an oncogene must be in an environment per-
missive for tumor development [87]. Thus, if conditions did
not favor tumorigenesis, no tumor would grow. In another
study, Hochedlinger et al. utilized nuclear transplantation to
introduce nuclei from malignant cancer cells into enucleated
oocytes, which were subsequently used to produce chimeric
mice [88]. Even though the mice had a predisposition
for a tumorigenic phenotype, the majority of their tissues
were normal; regulated by the “normal,” nontumorigenic
microenvironment of the enucleated oocyte [88].
The tissue microenvironment has additionally been
determined to play a pivotal role in cancer progression and
metastasis. In an investigation of gene expression during
tumor progression in the breast, it was found that exten-
sive changes in gene expression occur in tumor-associated
stroma, including increased expression of MMP2, MMP11,
and MMP14 during the transition from a preinvasive to
invasive phenotype [89]. In addition, bone metastatic breast
cancer cells coopt native bone cells like the osteoblast to
increase their production of the inﬂammatory cytokines IL-
6, MCP-1, VEGF, MIP-2 (human IL-8), and KC (human
GRO-α)[ 90]. These results suggest that (1) the tumor
microenvironment plays a role in tumorigenesis prior to
tumor cell invasion of the stroma and that (2) cancer cells
coopt the normal cells of the microenvironment to facilitate8 International Journal of Cell Biology
cancer cell colonization. Thus, the cellular microenviron-
ment can no longer be viewed as an innocent bystander to
tumor progression.
Several recent studies, in particular, have directly exam-
ined the interaction of cancer cells with the microenviron-
ment. In one experiment, Booth et al. investigated whether
carcinogenic Mouse Mammary Tumor Virus- (MMTV-)
neu-transformed cells could be directed by the microenvi-
ronment of the normal mouse mammary gland to partic-
ipate in the development of a functional mammary gland
[91]. In order to examine this question, MMTV-neu cells
werecollected from WAP-Cre/Rosa26R/MMTV-neu tumors,
mixed with wild-type primary mammary epithelial cells,
and subsequently inoculated into the epithelium-divested
fat pads of female athymic nude mice [91]. It was found
that, when mixed with wild-type mammary epithelial cells
from primary mammary epithelial cell cultures, epithelial
progeny contributed by the MMTV-neu-transformed cells
participated in normal mammary gland development [91].
In another experiment, Bussard et al. showed that human
embryonal carcinoma cells could be redirected from their
tumorigenic phenotype to diﬀerentiation into functional
bona ﬁde human-speciﬁc mammary epithelial cells through
interaction with the mouse mammary microenvironment
in vivo [83]. When human embryonal carcinoma cells were
inoculated with mouse mammary epithelial cells into the
epithelium-divested fat pad of female athymic nude mice,
redirected human embryonal carcinoma cells contributed
to the formation of a normal mammary gland, expressed
human-speciﬁc keratins, as well as secreted human-speciﬁc
milk proteins in lactating hosts [83]. When human embry-
onal carcinoma cells were inoculated alone (without mam-
mary epithelial cells) into the epithelium-divested fat pad of
female athymic nude mice, tumors formed in both the ﬁrst-
andsecond-generationoutgrowths[83].Mostrecently,itwas
demonstrated that, when mixed with normal mouse mam-
mary epithelial cells, human bone metastatic, nonmetastatic,
and metastasis-suppressed breast cancer cells expressed the
normal human mammary epithelial cell markers in the ﬁrst
and second transplant generations (Bussard, unpublished).
Thus, these results as a whole not only suggest that cancer
cells can respond to “normal” developmental cues but also
furthergiveevidenceincertainsituations,forthedominance
of a “normal” microenvironment over tumor development.
11. Conclusions and FutureConsiderations
Data have shown that signals from the tissue microenviron-
ment inﬂuence progenitor cell fate. In order to study signals
by the tissue microenvironment on progenitor cells, the
mammary gland has served as a robust model system. It was
found that the mammary gland niche (microenvironment)
plays a pivotal role in glandular development and direction
ofepithelialcellfate.Furthermore,ithasbeenrecentlyshown
thatthemammaryglandmicroenvironmentcanalsoredirect
somatic cells from other tissues (adult testicular, bona ﬁde
neural stem cells, and human embryonal carcinoma cells)
to behave and function as mammary epithelial cells. These
results show that nonnative somatic cells interact with and
respond to signals from the mouse mammary gland and
are capable of being directed to diﬀerentiate into cells that
exhibit diverse mammary epithelial cell phenotypes. These
observations demonstrate dominance of the tissue niche
over progenitor/cancer cell fate. While speciﬁc molecular
mechanisms for these phenomena have yet to be deter-
mined, these data add provocative information toward the
understanding of cell plasticity. Understanding mechanisms
pertaining to cellular reprogramming would create a new
therapeutic avenue for disease treatment, as well as prolong
time of survival and improve quality of life for patients with
debilitating diseases.
Many questions, however, still remain. Why is it that
this integration event only occurs when the number of
normal, native epithelial cells is more than nonnative
cells? What are the mechanisms by which these events
occur? Can the reprogramming of progenitor cells occur
in organs besides the mammary gland? Are there limits
to the type/number of cells that can be reprogrammed?
The answers to these as well as other questions will assist
in deciphering the complex signaling that occurs between
the tissue microenvironment and progenitor cells. Teasing
out speciﬁc combinations of cell-cell and cell-extracellular
matrix interactions such as those demonstrated by LaBarge
et al. appear to be a good start and provide insight into
the mechanisms by which cellular reprogramming by the
niche occurs [71]. It is likely that a multitude of interacting
factors and pathways are necessary to redirect cellular
fate in vivo. Regardless, understanding the complexity of
these interactions will not only help decode the molecular
intricacies of the mammary gland but also aid in under-
standingstemcellbiologyandneoplastictransformationasa
whole.
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